Total Assets for Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported total assets is $26.14B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal AssetsSwitch metric
Latest period
$26.14B
YoY change
+16.0%
5Y CAGR
+17.3%
Peak year (2025)
$26.14B
Latest annual
$26.14B
Total Assets history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
Total Assets history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $26.14B | +16.0% | ||
| 2024 | $22.53B | -0.9% | ||
| 2023 | $22.73B | +25.2% | ||
| 2022 | $18.15B | +35.1% | ||
| 2021 | $13.43B | +14.3% | ||
| 2020 | $11.75B | +41.3% | ||
| 2019 | $8.32B | +33.2% | ||
| 2018 | $6.25B | +76.1% | ||
| 2017 | $3.55B | +22.5% | ||
| 2016 | $2.89B | +15.9% | ||
| 2015 | $2.50B | +6.9% | ||
| 2014 | $2.34B | +0.7% | ||
| 2013 | $2.32B | -16.0% | ||
| 2012 | $2.76B | +25.2% | ||
| 2011 | $2.20B | +27.8% | ||
| 2010 | $1.73B | -11.8% | ||
| 2009 | $1.96B | +99.4% | ||
| 2008 | $980.48M | +63.0% | ||
| 2007 | $601.48M | -34.7% | ||
| 2006 | $921.58M | +67.9% | ||
| 2005 | $549.00M | +0.6% | ||
| 2004 | $545.45M | -24.7% | ||
| 2003 | $724.41M | -11.2% | ||
| 2002 | $815.72M | -11.8% | ||
| 2001 | $925.13M | +19.7% | ||
| 2000 | $772.88M | +232.6% | ||
| 1999 | $232.40M | -12.7% | ||
| 1998 | $266.30M | -9.9% | ||
| 1997 | $295.60M | +106.0% | ||
| 1996 | $143.50M | +44.9% | ||
| 1995 | $99.00M | -14.8% | ||
| 1994 | $116.20M | +90.5% | ||
| 1993 | $61.00M | +19.6% | ||
| 1992 | $51.00M | -10.7% | ||
| 1991 | $57.10M | +520.7% | ||
| 1990 | $9.20M | — |
Total Assets values are taken from Vertex Pharmaceuticals's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Vertex Pharmaceuticals (VRTX) total assets is $26.14B – grew 16.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Vertex Pharmaceuticals total assets compounded at +17.3% per year, with the latest reading among the more recent periods of the dataset.
The dataset's maximum total assets sits at $26.14B (2025); the minimum reading of $9.20M dates to 1990.
Within Healthcare, Vertex Pharmaceuticals (VRTX) ranks 9th among 8 peers we track. The peer median for total assets is $135.41B.
Vertex Pharmaceuticals Total Assets by Year
Vertex Pharmaceuticals Total Assets 2025: $26.14B
Vertex Pharmaceuticals total assets in 2025 was $26.14B, grew 16.0% from 2024. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals Total Assets 2024: $22.53B
Vertex Pharmaceuticals total assets in 2024 was $22.53B, edged down 0.9% below 2023.
Vertex Pharmaceuticals Total Assets 2023: $22.73B
Vertex Pharmaceuticals total assets in 2023 was $22.73B, grew 25.2% from 2022.
Vertex Pharmaceuticals Total Assets 2022: $18.15B
Vertex Pharmaceuticals total assets in 2022 was $18.15B, surged 35.1% from 2021.
Vertex Pharmaceuticals Total Assets 2021: $13.43B
Vertex Pharmaceuticals total assets in 2021 was $13.43B.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers — Total Assets
Companies in the same sector as Vertex Pharmaceuticals, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Vertex Pharmaceuticals's total assets?
- Latest reported total assets for Vertex Pharmaceuticals (VRTX) is $26.14B (period ending December 31, 2025).
How has Vertex Pharmaceuticals total assets changed year-over-year?
- Vertex Pharmaceuticals (VRTX) total assets changed +16.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Vertex Pharmaceuticals total assets?
- Vertex Pharmaceuticals (VRTX) total assets compound annual growth rate is +17.3% over the most recent 5 years available.
When did Vertex Pharmaceuticals total assets hit its highest annual value?
- Vertex Pharmaceuticals total assets reached its highest annual value of $26.14B in 2025.
What was Vertex Pharmaceuticals total assets in 2024?
- Vertex Pharmaceuticals (VRTX) total assets in 2024 was $22.53B.
What was Vertex Pharmaceuticals total assets in 2025?
- Vertex Pharmaceuticals (VRTX) total assets in 2025 was $26.14B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
VRTX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.